Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nicole Massoll

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
9
2022
111
1.330
 Why?
Thyroid Nodule
5
2022
31
1.180
 Why?
Carcinoma, Papillary
4
2017
49
0.670
 Why?
Biopsy, Fine-Needle
7
2024
108
0.620
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
61
0.540
 Why?
Uterus
2
2008
87
0.540
 Why?
Papillomavirus Infections
2
2008
168
0.470
 Why?
Breast Neoplasms
7
2018
1181
0.400
 Why?
Vulvar Neoplasms
3
2008
59
0.360
 Why?
Carcinoma, Squamous Cell
4
2008
326
0.360
 Why?
Cysts
2
2006
51
0.330
 Why?
MicroRNAs
3
2022
349
0.330
 Why?
Uterine Cervical Neoplasms
2
2008
276
0.300
 Why?
Uterine Cervical Dysplasia
1
2008
49
0.300
 Why?
Precancerous Conditions
1
2008
83
0.290
 Why?
Carcinoma, Lobular
1
2007
33
0.280
 Why?
Cytological Techniques
1
2006
14
0.270
 Why?
Carcinoma, Ductal, Breast
1
2007
89
0.270
 Why?
Adenomyoma
1
2005
2
0.260
 Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.260
 Why?
Carcinoma in Situ
2
2008
73
0.250
 Why?
Gynecologic Surgical Procedures
1
2005
28
0.250
 Why?
Biopsy, Needle
1
2006
181
0.250
 Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.250
 Why?
Uterine Neoplasms
1
2005
60
0.250
 Why?
Lymph Nodes
3
2017
261
0.250
 Why?
Competency-Based Education
1
2024
28
0.240
 Why?
Carcinoma, Medullary
1
2004
12
0.230
 Why?
Humans
34
2024
49863
0.220
 Why?
Fellowships and Scholarships
1
2024
116
0.220
 Why?
Adenocarcinoma, Follicular
1
2002
4
0.210
 Why?
Mastectomy
2
2018
141
0.210
 Why?
Thyrotropin
1
2002
47
0.210
 Why?
Clinical Competence
1
2024
393
0.190
 Why?
Pathology
3
2024
38
0.190
 Why?
Female
21
2020
26520
0.180
 Why?
Focal Adhesion Kinase 1
2
2012
15
0.180
 Why?
Diagnostic Tests, Routine
1
2020
28
0.180
 Why?
Carcinoma, Neuroendocrine
1
2020
23
0.180
 Why?
Diagnosis, Differential
4
2008
1038
0.180
 Why?
Mutation
6
2022
1290
0.180
 Why?
Lung Neoplasms
2
2015
600
0.170
 Why?
DNA, Neoplasm
2
2018
145
0.170
 Why?
Protein Kinase Inhibitors
2
2012
205
0.160
 Why?
Proto-Oncogene Proteins B-raf
2
2017
79
0.160
 Why?
Immunohistochemistry
6
2015
983
0.150
 Why?
Thyroid Gland
3
2020
73
0.140
 Why?
Middle Aged
11
2020
12258
0.140
 Why?
Pancreatic Neoplasms
2
2010
209
0.140
 Why?
Gene Silencing
2
2008
114
0.140
 Why?
Neoplasm Invasiveness
5
2015
268
0.140
 Why?
DNA, Viral
2
2008
133
0.130
 Why?
Sensitivity and Specificity
4
2020
855
0.130
 Why?
PTEN Phosphohydrolase
1
2016
53
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Fibroblasts
2
2016
352
0.130
 Why?
Cytodiagnosis
1
2015
42
0.130
 Why?
Aged, 80 and over
6
2020
3132
0.120
 Why?
Adult
10
2020
13325
0.120
 Why?
Cell Proliferation
4
2016
999
0.120
 Why?
Endosonography
1
2015
94
0.120
 Why?
Granuloma
2
2007
45
0.120
 Why?
Lymphatic Metastasis
3
2017
226
0.120
 Why?
Receptor, erbB-2
2
2018
74
0.110
 Why?
Laryngeal Diseases
1
2013
12
0.110
 Why?
Herpes Simplex
1
2013
21
0.110
 Why?
Laryngectomy
1
2013
27
0.110
 Why?
Purine Nucleosides
1
2012
3
0.110
 Why?
Receptor, IGF Type 1
1
2012
20
0.100
 Why?
Immunoenzyme Techniques
2
2008
144
0.090
 Why?
Cell Movement
2
2009
245
0.090
 Why?
Predictive Value of Tests
2
2020
907
0.090
 Why?
Receptors, Somatomedin
1
2010
8
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.080
 Why?
Tissue Fixation
2
2020
36
0.080
 Why?
Retrospective Studies
5
2022
6106
0.080
 Why?
Aniline Compounds
1
2009
42
0.080
 Why?
Melanoma
1
2012
282
0.080
 Why?
Promoter Regions, Genetic
2
2008
467
0.080
 Why?
Aged
6
2020
9434
0.080
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
 Why?
Neuroblastoma
1
2008
53
0.080
 Why?
Transglutaminases
1
2008
15
0.080
 Why?
Proto-Oncogene Proteins c-met
1
2007
19
0.070
 Why?
Mastitis
1
2007
3
0.070
 Why?
Biopsy
2
2007
591
0.070
 Why?
Genetic Markers
1
2008
102
0.070
 Why?
GTP-Binding Proteins
1
2008
92
0.070
 Why?
Genes, erbB-2
1
2007
8
0.070
 Why?
Prednisone
1
2007
100
0.070
 Why?
Gene Expression Regulation, Enzymologic
1
2008
178
0.070
 Why?
Group Practice
1
2006
3
0.070
 Why?
Intracellular Signaling Peptides and Proteins
1
2007
139
0.070
 Why?
Cystatins
1
2006
1
0.070
 Why?
Cadherins
1
2007
64
0.070
 Why?
Frozen Sections
1
2006
13
0.070
 Why?
Specialization
1
2006
46
0.070
 Why?
Genomic Instability
1
2007
91
0.070
 Why?
Colonic Neoplasms
1
2008
158
0.070
 Why?
Tumor Suppressor Protein p53
1
2008
214
0.070
 Why?
Polymerase Chain Reaction
2
2005
453
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
594
0.070
 Why?
Mice
6
2017
5671
0.070
 Why?
Medicine
1
2006
56
0.070
 Why?
Nuclear Proteins
1
2007
240
0.070
 Why?
RNA, Small Interfering
3
2012
215
0.070
 Why?
Carrier Proteins
1
2007
302
0.070
 Why?
Mullerian Ducts
1
2005
4
0.060
 Why?
Antigens, CD
1
2007
218
0.060
 Why?
Gene Expression
1
2008
613
0.060
 Why?
Fallopian Tubes
1
2005
22
0.060
 Why?
Signal Transduction
1
2012
1605
0.060
 Why?
Medical Oncology
1
2006
95
0.060
 Why?
Estrogen Replacement Therapy
1
2005
28
0.060
 Why?
Vulva
1
2005
17
0.060
 Why?
ABO Blood-Group System
1
2005
15
0.060
 Why?
Data Collection
1
2006
283
0.060
 Why?
Ovariectomy
1
2005
113
0.060
 Why?
Glucocorticoids
1
2007
228
0.060
 Why?
Chromosome Aberrations
1
2007
295
0.060
 Why?
Hysterectomy
1
2005
88
0.060
 Why?
Decision Making
1
2007
270
0.060
 Why?
Mice, Nude
3
2010
252
0.060
 Why?
Regression Analysis
1
2006
385
0.060
 Why?
Carcinoma, Transitional Cell
1
2005
52
0.060
 Why?
Epithelial Cells
1
2006
209
0.060
 Why?
Male
7
2020
25439
0.060
 Why?
Papillomaviridae
1
2005
102
0.060
 Why?
Cell Survival
3
2012
590
0.060
 Why?
Epigenesis, Genetic
1
2008
369
0.060
 Why?
Cell Line, Tumor
4
2009
1387
0.060
 Why?
Cohort Studies
2
2020
1400
0.060
 Why?
Ultrasonography
1
2006
428
0.060
 Why?
Prospective Studies
2
2022
2341
0.050
 Why?
Base Sequence
3
2010
644
0.050
 Why?
Gene Expression Regulation
1
2007
972
0.050
 Why?
Education, Medical, Graduate
1
2024
210
0.050
 Why?
Thyroidectomy
1
2002
59
0.050
 Why?
Gene Expression Profiling
1
2007
1029
0.050
 Why?
Adolescent
3
2015
6392
0.050
 Why?
Yersinia pseudotuberculosis
1
2001
4
0.050
 Why?
Yersinia Infections
1
2001
6
0.050
 Why?
Yersinia enterocolitica
1
2001
6
0.050
 Why?
Animals
6
2017
13133
0.050
 Why?
Recombinant Proteins
1
2002
488
0.050
 Why?
Combined Modality Therapy
1
2002
638
0.050
 Why?
Formaldehyde
1
2020
50
0.040
 Why?
Oncogenes
1
2020
57
0.040
 Why?
Appendicitis
1
2001
59
0.040
 Why?
Disease Progression
3
2008
822
0.040
 Why?
Cell Differentiation
1
2002
651
0.040
 Why?
Neoplasm Staging
2
2015
748
0.040
 Why?
Transplantation, Heterologous
2
2010
75
0.040
 Why?
Toxicology
1
1999
29
0.040
 Why?
Antineoplastic Agents
1
2008
1173
0.040
 Why?
Blotting, Western
2
2012
600
0.040
 Why?
DNA Methylation
3
2008
544
0.040
 Why?
DNA Primers
2
2010
207
0.040
 Why?
Young Adult
2
2020
4013
0.040
 Why?
Paraffin Embedding
1
2018
52
0.040
 Why?
Specimen Handling
1
2018
54
0.040
 Why?
Receptors, Progesterone
1
2018
63
0.040
 Why?
Receptors, Estrogen
1
2018
130
0.040
 Why?
Lymphatic System
1
2017
13
0.040
 Why?
Methylene Blue
1
2017
10
0.040
 Why?
Animals, Genetically Modified
1
2017
48
0.040
 Why?
Coloring Agents
1
2017
67
0.040
 Why?
Mice, Inbred Strains
1
2017
161
0.040
 Why?
Prognosis
2
2015
1948
0.030
 Why?
Follow-Up Studies
2
2015
2174
0.030
 Why?
Treatment Outcome
1
2006
5165
0.030
 Why?
Cost Savings
1
2015
58
0.030
 Why?
Apoptosis
2
2012
1102
0.030
 Why?
Mice, Knockout
2
2008
842
0.030
 Why?
Neoplasm Grading
1
2015
123
0.030
 Why?
RNA, Messenger
2
2008
1101
0.030
 Why?
Collagen
1
2016
209
0.030
 Why?
Cost-Benefit Analysis
1
2015
269
0.030
 Why?
Tumor Microenvironment
1
2016
221
0.030
 Why?
Immunoprecipitation
1
2012
58
0.030
 Why?
In Situ Nick-End Labeling
1
2012
57
0.030
 Why?
Flow Cytometry
1
2012
473
0.020
 Why?
Staurosporine
1
2009
12
0.020
 Why?
Cell Line
1
2012
1012
0.020
 Why?
Deoxycytidine
1
2009
28
0.020
 Why?
Drug Synergism
1
2009
150
0.020
 Why?
Cell Adhesion
1
2009
157
0.020
 Why?
RNA Interference
1
2009
178
0.020
 Why?
Xenograft Model Antitumor Assays
1
2009
212
0.020
 Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
 Why?
Chromatin Immunoprecipitation
1
2008
48
0.020
 Why?
Luciferases
1
2008
50
0.020
 Why?
Adenoviridae
1
2008
51
0.020
 Why?
Florida
1
2008
56
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
 Why?
Fluorouracil
1
2008
55
0.020
 Why?
Loss of Heterozygosity
1
2008
77
0.020
 Why?
Histone Deacetylase 2
1
2007
4
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2008
101
0.020
 Why?
Phosphorylation
1
2009
526
0.020
 Why?
Transcriptional Activation
1
2008
118
0.020
 Why?
Co-Repressor Proteins
1
2007
18
0.020
 Why?
Estrogens
1
2009
222
0.020
 Why?
Sequence Deletion
1
2007
68
0.020
 Why?
Drug Screening Assays, Antitumor
1
2008
131
0.020
 Why?
Transfection
1
2008
352
0.020
 Why?
Molecular Chaperones
1
2007
63
0.020
 Why?
Histone Deacetylases
1
2007
50
0.020
 Why?
Enzyme Inhibitors
1
2009
378
0.020
 Why?
Ultrasonography, Mammary
1
2007
61
0.020
 Why?
Chromatin
1
2007
134
0.020
 Why?
Kaplan-Meier Estimate
1
2008
463
0.020
 Why?
Tumor Cells, Cultured
1
2007
460
0.020
 Why?
Transcription, Genetic
1
2008
366
0.020
 Why?
Cystatin M
1
2006
19
0.020
 Why?
Molecular Sequence Data
1
2008
791
0.020
 Why?
5' Untranslated Regions
1
2006
31
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Repressor Proteins
1
2007
150
0.020
 Why?
Carcinoma
1
2007
139
0.020
 Why?
Down-Regulation
1
2007
347
0.020
 Why?
Wound Healing
1
2007
204
0.020
 Why?
Cesarean Section
1
2007
159
0.020
 Why?
Protein Binding
1
2007
653
0.020
 Why?
Survival Rate
1
2008
904
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2009
822
0.020
 Why?
Chi-Square Distribution
1
2005
275
0.010
 Why?
Cells, Cultured
1
2008
1579
0.010
 Why?
Neoplasm Recurrence, Local
1
2008
627
0.010
 Why?
Pregnancy Complications
1
2007
363
0.010
 Why?
Child
2
2008
6838
0.010
 Why?
Tomography, X-Ray Computed
1
2007
1152
0.010
 Why?
Appendix
1
2001
23
0.010
 Why?
Infant, Newborn
1
2008
2725
0.010
 Why?
DNA, Bacterial
1
2001
187
0.010
 Why?
Magnetic Resonance Imaging
1
2007
1526
0.010
 Why?
Pregnancy
1
2007
2469
0.010
 Why?
Environmental Medicine
1
1999
1
0.010
 Why?
Occupational Medicine
1
1999
4
0.010
 Why?
History, Ancient
1
1999
9
0.010
 Why?
Forensic Medicine
1
1999
7
0.010
 Why?
History, 19th Century
1
1999
22
0.010
 Why?
Infant
1
2008
3565
0.010
 Why?
Risk Factors
1
2008
3597
0.010
 Why?
Child, Preschool
1
2008
3872
0.010
 Why?
History, 20th Century
1
1999
95
0.010
 Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department